Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

Circulation

Volumn 101, Issue 4, 2000, Pages 385-391

  Müller, Johannes ^a   Wallukat, Gerd ^b   Dandel, Michael ^a   Bieda, Heidrun ^a   Brandes, Kersten ^a   Spiegelsberger, Susanne ^a   Nissen, Eberhard ^b   Kunze, Rudolf ^c   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c IMTOX   (Germany)

Author keywords

Autoantibodies; Dilated cardiomyopathy

Indexed keywords

ANTIBODY; BETA 1 ADRENERGIC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOADSORPTION; MALE; PRIORITY JOURNAL;

EID: 0034141699     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.4.385     Document Type: Article

References (46)

1. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation, fourteenth official report 1997. J Heart Lung Transplant. 1997;16:691-712.
2. Klein R, Maisch B, Kochsiek K, Berg PA. Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol. 1984;58: 283-292.
3. Schulze K, Becker BF, Schauer R, Schultheiss HP. Antibodies to ADP-ATP carrier - an autoantigen in myocarditis and dilated cardiomyopathy - impair cardiac function. Circulation. 1990;81:959-969.
4. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S. Identification of α- and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation. 1992;85:1734-1742.
5. Wallukat G, Wollenberger A. Effects of serum gamma globulin fractions of patients with allergic asthma and dilated cardiomyopathy on chronotropic β-adrenoceptor function in cultured neonatal rat heart myocytes. Biomed Biochim Acta. 1987;46:634-639.
6. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against beta-adrenoceptors in human dilated cardiomyopathy. Circ Res. 1989;64: 97-103.
7. Limas CJ. Cardiac autoantibodies in dilated cardiomyopathy: a pathogenetic role? Circulation. 1997;95:1979-1980.
8. Caforio AL, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, Bottazzo GF, McKenna WJ. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet. 1994;344:773-777.
9. Matsui S, Fu ML, Katsuda S, Hayase M, Yamaguchi N, Teraoka K, Kurihara T, Takekoshi N, Murakami E, Hoebeke J, Hjalmarson Å. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol. 1997;29:641-655.
10. 1-adrenergic receptor expression in neonatal rat cardiomyocytes. Circulation. 1998;98:2470-2476.
11. 1-adrenoceptor autoantibodies from patients with idiopathic dilated cardiomyopathy. Blood Press Suppl. 1996;3:37-40.
12. Müller J, Wallukat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, Hetzer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;96:542-549.
13. Borda ES, Pascual J, Cossio PM, Vega M, Arana RM, Sterin-Borda L. Circulating IgG in Chagas disease which binds to β-adrenoceptor of myocardium and modulates its activity. Clin Exp Immunol. 1984;57: 679-686.
14. Berta E, Confalonieri P, Simoncini O, Bernardi G, Busnach G, Mantegazza R, Cornelio F, Antozzi C. Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis. Int J Artif Organs. 1994;17:603-608.
15. Mittelman A, Puccio C, Ahmed T, Arlin Z, Wuest D, Ciavarella D, Seawell BW, Snyder HW Jr. Response of refractory thrombotic thrombocytopenic purpura to extracorporeal immunoadsorption. N Engl J Med. 1992;326:711-712.
16. Uehlinger J, Rose E, Aledort LM, Lemer R. Successful treatment of an acquired von Willebrand factor antibody by extracorporeal immunoadsorption. N Engl J Med. 1989;320:254-255.
17. Wallukat G, Reinke P, Dörffel WV, Luther HP, Bestvater K, Felix SB, Baumann G. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol. 1996;54:191-195.
18. Dolgin M, ed. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, Mass: Little, Brown & Co; 1994:240.
19. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med. 1997;336:1350-1355.
20. Reinke P, Brehme S, Baumann G, Koll R, Müller-Derlich J, Felix S, Spaethe R. Treatment of cardiomyopathy by removal of autoantibodies. International application published under the Patent Cooperation Treaty (PCT). International publication number WO 97/1798. International application number PCT/US96/18457.
21. Wallukat G, Wollenberger A, Morwinski R, Pitschner HF. Anti-beta 1-adrenoceptor antibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol. 1995;27:397-406.
22. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD. ACC/AHA Guidelines for the Clinical Application of Echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) developed in collaboration with the American Society of Echocardiography. Circulation. 1997;95: 1686-1744.
23. Feigenbaum H. Echocardiographic evaluation of cardiac chambers. In: Feigenbaum H, ed. Echocardiography. Philadelphia, Pa: Lea & Febiger, 1994:134-180.
24. Fahrmeir L, Hamerle A. Multivariate statistische Verfahren. Berlin, Germany: Walter de Gruyter; 1984.
25. Bortz J, Lienert GA, Boehnke K. Verteilungsfreie Methoden in der Biostatistik. Heidelberg, Germany: Springer; 1990.
26. Box GEP. Non-normality and tests on variance. Biometrika. 1953;40: 318-335.
27. Box GEP. Some theorems on quadratic forms applied in the study of analysis of variance problems, I: effect of inequality of variances in the one-way classification. Ann Mathemat Stat. 1954;25:290-302.
28. Dörffel WV, Felix SB, Wallukat G, Brehme S, Bestvater K, Hofmann T, Kleber FX, Baumann G, Reinke P. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation. 1997;95: 1994-1997.
29. Ross J Jr. Assessment of cardiac function and myocardial contractility. In: Alexander RW, Schlant RC, Fuster V, eds. Hurst's The Heart. 9th ed. New York, NY: McGraw-Hill; 1998:727-743.
30. Lejemtel TH, Sonnenblick EH, Frishmann W. Diagnosis and management of heart failure. In: Alexander RW, Schlant RC, Fuster V, eds. Hurst's The Heart. 9th ed. New York, NY: McGraw-Hill; 1998:745-781.
31. Feigenbaum H. Echocardiographic examination of the left ventricle. Circulation. 1975;51:1-7.
32. Feigenbaum H. Echocardiography. In: Braunwald E, ed. Heart Disease. 4th ed. Philadelphia, Pa: WB Saunders; 1992:64-115.
33. Vuille C, Weyman AE. Left ventricle, I: general considerations, assessment of chamber size and function. In: Weyman AE, ed. Principles and Practice of Echocardiography. 2nd ed. Philadelphia, Pa: Lea & Febiger; 1994:557-624.
34. De Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol. 1994;23:1444-1451.
35. Reichek N, Wilson J, St John Sutton M, Plappert TA, Goldberg S, Hirshfeld JW. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation. 1982; 65:99-108.
36. Aurigemma GP, Douglas PS, Gaasch WH. Quantitative evaluation of left ventricular structure, wall stress and systolic function. In: Otto CM, ed. The Practice of Clinical Echocardiography. Philadelphia, Pa: WB Saunders; 1997:1-24.
37. Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C, Shelton B. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD echocardiography substudy. Circulation. 1995;91: 2573-2581.
38. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
39. Packer M. Effects of beta-adrenergic blockade on survival of patients with chronic heart failure. Am J Cardiol. 1997;80:46L-54L.
40. Fowler MB. Effects of beta blockers on symptoms and functional capacity in heart failure. Am J Cardiol. 1997;80:55L-58L.
41. Waagstein F. Efficacy of beta blockers in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy. Am J Cardiol. 1997;80:45J-49J.
42. Hurrell DG, Nishimura RA, Ilstrup DM, Appleton CP. Utility of preload alteration in assessment of left ventricular filling pressure by Doppler echocardiography: a simultaneous characterization and Doppler echocardiographic study. J Am Coll Cardiol. 1997;30:459-467.
43. Lewis JF. Doppler and two-dimensional echocardiographic evaluation in acute and long term management of the heart failure patient. In: Otto CM, ed. The Practice of Clinical Echocardiography. Philadelphia, Pa: WB Saunders, 1997:433-448.
44. 1-adrenoceptor as antigen: functional aspects. Eur Heart J. 1995;16:85-88.
45. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson Å, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy: characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation. 1994;89:2760-2767.
46. Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med. 1999;340: 227-228.